肥胖悖论与脓毒症功能结局:一项多中心前瞻性研究
该多中心前瞻性观察研究纳入韩国19家三级转诊或大学附属医院的成人脓毒症患者6424例,分为肥胖组1335例和非肥胖组5089例,并按1:1倾向性评分匹配。主要终点院内死亡率在匹配后非肥胖组高于肥胖组(25.3% vs 36.7%,p<0.001)。肥胖组出院回家率更高(70.3% vs 65.2%,p<0.001)、出院时中位临床衰弱量表评分更低(4 vs 5,p=0.007),非肥胖组出院时衰弱(CFS≥5)比例显著更高(48.7% vs 54.7%,p=0.011)。按WHO体重指数分类进一步分析显示,以正常BMI为参照,低体重、超重和肥胖患者的院内死亡调整比值比分别为1.25(p=0.004)、0.58(p<0.001)、0.70(p=0.047),出院时衰弱的调整比值比分别为1.53(p<0.001)、0.80(p=0.095)、0.60(p=0.022)。
要点
- 倾向性评分匹配后,非肥胖组院内死亡率高于肥胖组(25.3% vs 36.7%,p<0.001)。
- 肥胖组出院回家率更高(70.3% vs 65.2%,p<0.001),出院时中位CFS更低(4 vs 5,p=0.007)。
- 非肥胖组出院时衰弱(CFS≥5)比例显著更高(48.7% vs 54.7%,p=0.011)。
- 以正常BMI为参照,低体重患者院内死亡调整OR为1.25(p=0.004),超重为0.58(p<0.001),肥胖为0.70(p=0.047)。
- 以正常BMI为参照,低体重患者出院时衰弱调整OR为1.53(p<0.001),超重为0.80(p=0.095),肥胖为0.60(p=0.022)。
适用人群与场景
- 韩国19家三级转诊医院或大学附属医院的成人脓毒症患者,共6424例,其中肥胖组1335例、非肥胖组5089例。
- 研究纳入时间为2019年9月至2020年12月。
诊断标准与关键阈值
- 按世界卫生组织体重指数分类将患者分为四组进行附加分析。
- 出院时衰弱定义为临床衰弱量表(CFS)≥5。
研究设计与关键结果
- 多中心、前瞻性、观察性研究,纳入韩国19家三级转诊医院或大学附属医院的成人脓毒症患者6424例,肥胖组1335例与非肥胖组5089例按1:1倾向性评分匹配。
- 主要终点院内死亡率:匹配后非肥胖组高于肥胖组(25.3% vs 36.7%,p<0.001)。
- 肥胖组出院回家率高于非肥胖组(70.3% vs 65.2%,p<0.001)。
- 肥胖组出院时中位CFS低于非肥胖组(4 vs 5,p=0.007)。
- 非肥胖组出院时衰弱(CFS≥5)比例显著高于肥胖组(48.7% vs 54.7%,p=0.011)。
- 以正常BMI为参照,低体重、超重和肥胖患者院内死亡的调整OR分别为1.25(p=0.004)、0.58(p<0.001)、0.70(p=0.047)。
- 以正常BMI为参照,低体重、超重和肥胖患者出院时衰弱的调整OR分别为1.53(p<0.001)、0.80(p=0.095)、0.60(p=0.022)。
证据类型、等级与局限
- 证据类型:多中心、前瞻性、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在亚洲脓毒症患者中,肥胖与更高的院内生存率和出院时更好的功能结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: In Asian populations, the correlation between sepsis outcomes and body mass is unclear. A multicenter, prospective, observational study conducted between September 2019 and December 2020 evaluated obesity's effects on sepsis outcomes in a national cohort.
SETTING: Nineteen tertiary referral hospitals or university-affiliated hospitals in South Korea.
PATIENTS: Adult patients with sepsis ( n = 6,424) were classified into obese ( n = 1,335) and nonobese groups ( n = 5,089).
MEASUREMENTS AND RESULTS: Obese and nonobese patients were propensity score-matched in a ratio of 1:1. Inhospital mortality was the primary outcome. After propensity score matching, the nonobese group had higher hospital mortality than the obese group (25.3% vs 36.7%; p < 0.001). The obese group had a higher home discharge rate (70.3% vs 65.2%; p < 0.001) and lower median Clinical Frailty Scale (CFS) (4 vs 5; p = 0.007) at discharge than the nonobese group, whereas the proportion of frail patients at discharge (CFS ≥ 5) was significantly higher in the nonobese group (48.7% vs 54.7%; p = 0.011). Patients were divided into four groups according to the World Health Organization body mass index (BMI) classification and performed additional analyses. The adjusted odds ratio of hospital mortality and frailty at discharge for underweight, overweight, and obese patients relative to normal BMI was 1.25 ( p = 0.004), 0.58 ( p < 0.001), and 0.70 ( p = 0.047) and 1.53 ( p < 0.001), 0.80 ( p = 0.095), and 0.60 ( p = 0.022), respectively.
CONCLUSIONS: Obesity is associated with higher hospital survival and functional outcomes at discharge in Asian patients with sepsis.
参考来源
- Yeo HJ, Kim TH, Jang JH, et al. Obesity Paradox and Functional Outcomes in Sepsis: A Multicenter Prospective Study. Crit Care Med. 2023. PMID: 36762918. doi:10.1097/CCM.0000000000005801
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。